AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Evolving Strategies in Mantle Cell Lymphoma Treatment
This chapter examines the changing treatment options for mantle cell lymphoma (MCL), with a particular emphasis on the emergence of BTK inhibitors and the potential move away from chemotherapy. It discusses ongoing trials of targeted therapy combined with immunotherapy, signaling an optimistic future for patients with relapsed MCL.